December 4, 2025
On December 2, the Vaccine Integrity Project (VIP) released a study on the safety, effectiveness, and public health impact of hepatitis B virus (HBV) vaccinations at birth.
VIP, a project by the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, released the report two days before the Advisory Committee on Immunization Practice (ACIP) was scheduled to meet to discuss whether to end the practice of vaccinating all newborns for HBV. The practice has been in place since 1991.
VIP found the following in its review of data:
Given the long-term protection provided by the hepatitis B vaccine, the birth dose was also key in reducing HBV transmission, disease, and death in the U.S. overall.
No safety benefits were identified for a delayed first dose versus vaccination at birth.
Delaying the first dose leaves infants vulnerable to both undiagnosed maternal infection and HBV exposure after birth.
The data review found no benefit of delaying vaccinations.
See the full report here.
August 20, 2026
A physician and Olympian will give an inspirational address as part of this year's Empowering Physicians event on Friday, September 25, at the Minneapolis Institute of Art.
August 20, 2026
Minnesota received some disturbing news this week from the Centers for Disease Control and Prevention (CDC), as data shows that for the 2025-2026 school year, vaccination rates decreased and non-medical exemptions increased.
August 20, 2026
On August 11, a federal appellate court sided with the Texas Medical Association (TMA) argument that the way the No Surprises Act’s qualifying payment amount (QPA) is calculated has historically favored payers in arbitration.